GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
204 hedge funds and large institutions have $3.03B invested in GW Pharmaceuticals Plc American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 53 increasing their positions, 59 reducing their positions, and 26 closing their positions.
96% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 26
44% more capital invested
Capital invested by funds: $2.1B → $3.03B (+$927M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
13% more funds holding
Funds holding: 181 → 204 (+23)
10% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 59
12% less call options, than puts
Call options by funds: $75.8M | Put options by funds: $85.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$89.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$64.6M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$54.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$39.4M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$32.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$60.7M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$57.8M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$34.4M |
| 4 |
PP
Prudential plc
London, England,
United Kingdom
|
-$31.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.1M |
GWPH Hedge Fund Activity: Q4 2017 in Review
204 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2017, worth a combined $3.03B — up 44% from $2.1B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new GWPH positions and 26 closed out — a net gain of 25 holders — while 53 added to existing stakes and 59 trimmed.
The largest buyer was Capital World Investors, adding an estimated $89.3M. The largest seller was OrbiMed, cutting an estimated $60.7M.
- 204 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2017, up from 181 in Q3 2017.
- Funds reported $3.03B of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2017, up 44% quarter-over-quarter.
- 51 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2017 and 26 closed out, a net change of +25 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2017 was Capital World Investors, an estimated $89.3M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2017 was OrbiMed, an estimated $60.7M sold.
Based on aggregated 13F filings for Q4 2017.